Abstract
Objective: Increases in stress, anxiety, and depression among women pregnant during the COVID-19 pandemic have been reported internationally. Yet rigorous comparison of the prevalence of maternal mental health problems across countries is lacking. Moreover, whether stress is a common predictor of maternal mental health during the pandemic across countries is unknown. Methods: 8148 pregnant women from Germany, Israel, Italy, Poland, Spain, Switzerland, and the United States were enrolled in the International COVID-19 Pregnancy Experiences (I-COPE) Study between April 17 and May 31, 2020. Sociodemographic characteristics, pandemic-related stress, pregnancy-specific stress, anxiety, and depression were assessed with well-validated instruments. The magnitude of stress and mood disturbances was compared across countries. A path model predicting clinically significant levels of anxiety and depression from maternal characteristics and stress was tested for all study participants and then examined separately in each country with >200 participants. Results: Countries differed significantly in magnitude of pandemic-related pregnancy stress and pandemic-unrelated pregnancy-specific stress, and in prevalence of clinically significant anxiety and depression levels. A well-fitting common path model for the entire sample indicated that mood and anxiety disturbances were strongly predicted by pandemic-related and pregnancy-specific stress after accounting for maternal characteristics. The model was replicated in individual countries. Conclusions: Although pregnant women in high-income Western countries experienced different levels of stress resulting from the COVID-19 pandemic, stress is a strong, common predictor of anxiety and depressive symptoms in these individuals. The common model can be used to inform research and clinical interventions to protect against adverse consequences of prenatal maternal stress, anxiety, and depression for mothers and infants.
Original language | English |
---|---|
Article number | 115499 |
Journal | Social Science and Medicine |
Volume | 315 |
DOIs | |
State | Published - Dec 2022 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2022 Elsevier Ltd
Funding
Funding for the SB-COPE Study (United States) was provided by a Stony Brook University Office of the Vice President for Research and Institute for Engineering-Driven Medicine COVID-19 Seed Grant to Heidi Preis, Brittain Mahaffey, and Marci Lobel and a “Supplement for NIH Grants to Add or Expand Research Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19” funded by the NIH Office of the Director , Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone (IMPROVE) Program and the NIH/National Institute on Drug Abuse ( R21DA049827-02S1 ). No funding was provided to other I-COPE participants. The funding sources had no involvement in the conduct of the research or preparation of this article.
Funders | Funder number |
---|---|
Marci Lobel | |
National Institutes of Health | |
National Institute on Drug Abuse | R21DA049827 |
Keywords
- Anxiety
- COVID-19 global pandemic
- Depression
- Maternal stress
- Pregnancy
- Women's health